Arrowpoint Investment Partners Singapore Pte. Ltd. Acquires Shares of 7,920 Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• Arrowpoint Investment Partners Singapore Pte. Ltd. acquired 7,920 shares of Henry Schein, Inc. (NASDAQ:HSIC), valued at approximately $542,000, during the first quarter.
• The company's recent quarterly earnings report indicated EPS of $1.10, missing expectations, while revenues were up 3.3% year-over-year at $3.24 billion.
• Institutional investors now hold 96.62% of Henry Schein's stock, reflecting significant interest from multiple hedge funds in recent quarters.

Arrowpoint Investment Partners Singapore Pte. Ltd. acquired a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 7,920 shares of the company's stock, valued at approximately $542,000.

Several other institutional investors have also recently made changes to their positions in HSIC. Investment Management Corp VA ADV bought a new stake in Henry Schein during the 4th quarter worth approximately $32,000. Rakuten Securities Inc. bought a new stake in Henry Schein during the 1st quarter worth approximately $34,000. Whittier Trust Co. raised its stake in Henry Schein by 714.3% during the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after acquiring an additional 700 shares during the period. UMB Bank n.a. raised its stake in Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after acquiring an additional 201 shares during the period. Finally, Allworth Financial LP raised its stake in Henry Schein by 24.5% during the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after acquiring an additional 232 shares during the period. Institutional investors own 96.62% of the company's stock.

Henry Schein Price Performance

HSIC traded down $1.08 during trading hours on Thursday, hitting $67.91. The company's stock had a trading volume of 2,037,161 shares, compared to its average volume of 1,777,297. The stock has a market cap of $8.24 billion, a price-to-earnings ratio of 21.91, a P/E/G ratio of 2.23 and a beta of 0.81. The business's 50-day moving average price is $70.91 and its 200-day moving average price is $70.96. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter last year, the business earned $1.23 EPS. Henry Schein's revenue for the quarter was up 3.3% compared to the same quarter last year. Sell-side analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have commented on HSIC. Leerink Partners set a $75.00 target price on shares of Henry Schein in a research note on Monday, July 14th. JPMorgan Chase & Co. decreased their target price on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Robert W. Baird restated a "neutral" rating and set a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. UBS Group cut their price objective on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, August 6th. Finally, Baird R W lowered shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday, July 14th. Nine analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $75.58.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.